Latest news and research on all cancers and treatments, updated several times a week
- Do not smoke. Do not use any form of tobacco.
- Make your home smoke free. Support smoke-free policies in your workplace.
- Take action to be a healthy body weight.
- Be physically active in everyday life. Limit the time you spend sitting.
- Have a healthy diet: Eat plenty of whole grains, pulses, vegetables and fruits. Limit high-calorie foods (foods high in sugar or fat)and avoid sugary drinks. Avoid processed meat; limit red meat and foods high in salt.
- If you drink alcohol of any type, limit your intake. Not drinking alcohol is better for cancer prevention.
- Avoid too much sun, especially for children. Use sun protection. Do not use sunbeds.
- In the workplace, protect yourself against cancer-causing substances by following health and safety instructions.
- Find out if you are exposed to radiation from naturally high radon levels in your home. Take action to reduce high radon levels.
- For women: Breastfeeding reduces the mother’s cancer risk. If you can, breastfeed your baby. Hormone replacement therapy (HRT) increases the risk of certain cancers. Limit use of HRT.
- Ensure your children take part in vaccination programmes for: Hepatitis B (for newborns), Human papillomavirus (HPV) (for girls).
- Take part in organized cancer screening programmes for: Bowel cancer (men and women, Breast cancer (women), Cervical cancer (women).
The European Code Against Cancer focuses on actions that individual citizens can take to help prevent cancer.
Successful cancer prevention requires these individual actions to be supported by governmental policies and actions.
Find out more about the European Code Against Cancer at: European Code Against Cancer
Successful cancer prevention requires these individual actions to be supported by governmental policies and actions.
Find out more about the European Code Against Cancer at: European Code Against Cancer
[Thanks to Blandine Meyrieux-Lefevre for referencing this]
Good site for news, research, statistics, etc on cancer world-wide
The treatment of pancreatic cancer was made, perhaps, the most important discovery. A group of scientists from the French National Institute of Health ...
Opdivo, or nivolumab, targets a protein called PD-1, a molecular brake that prevents the immune system from seeing tumors as invaders and enables ...
New ways to treat cancer have also been discovered. Several types of treatment use the body's own natural defenses, or immune system, to fight ...
They work by blocking a mechanism tumors use to camouflage themselves from the immune system, allowing it to recognize and attack the cancer.
The best way to raise expectations of a new drug for cancer is its ... to modify the immune system cells and retrain them to attack blood cancers, ...
At the 2014 meeting of the American Society of Clinical Oncology, investigators reported practice-changing results from a randomized clinical trial in prostate cancer. In the accompanying video, Derek Raghavan, MD, PhD, uses the concept of money slides to offer a concise but accurate assessment of the trial results and implications.
Now, CNIO researchers clear this dilemma up for bladder cancer, in which it exerts an anti-tumour effect. This result calls for caution when using ...
How many people in our society know that smokers are almost 4 times more likely to get bladder cancer than non-smokers? It is estimated that 37% of ...
UroSens, a Cambridge UK company developing novel, non-invasive urine tests for the detection of prostate and bladder cancer, has received £2 ...
BCG is used to treat bladder cancer. According to the Mayo Clinic, BCG likely works by stimulating the body's immune system. Studies also show that ...
Roche said it expects pivotal data for its PD-L1 drug in lung and bladder cancer in the first half of this year, with potential filings seeking approval in the ...
The funding will also support a new research nurse at Leeds St James's, who will recruit bladder cancer patients into clinical trails and collect samples ...
We continue to work to advance our bladder cancer assay for the risk stratification of Non-muscle-invasive bladder cancer (NMIBC) patients.
Recently conducted research by Harvard University showed that 5 portions of cruciferous products can halve the risk of bladder cancer, which occurs ..
Bidness ETC
Jan 12 (Reuters) - Bristol-Myers Squibb and Merck & Co broke further away from rival drugmakers in the race to treat lung cancer with a new ...
Bristol-Myers scores lung cancer survival data on Opdivo as Merck preps for Keytruda filing - FiercePharma
AstraZeneca (AZ) has once again reaffirmed its commitment to researching cancer immunotherapies, forming a partnership with Omnis ...
Amgen (NASDAQ: AMGN) and The University of Texas MD Anderson Cancer Center today announced a research collaborative agreement focusing ...
Merck also said it would file an application midyear for expanding the use of its new cancer immunotherapy Keytruda to include the treatment of ...
KRAS is the most commonly mutated gene in the RAS family, and is involved in 95 percent of pancreatic cancer cases, and a high percentage of other ...
BUSINESS WIRE)--Aduro Biotech, Inc. today announced that results from a Phase 2 clinical trial of patients with metastatic pancreatic cancer were ...
“PANOVA is the first clinical study testing TTFields in pancreatic cancer,” said Uri Weinberg, MD, PhD, Vice President, Research and Development of ...
This cancer screening procedure didn't spread cancer cells in patients, ... Patients in this study who had a biopsy for pancreatic cancer lived longer ...
The biggest ongoing project is using the capsules in an attempt to fight pancreatic cancer. To date there is only one approved treatment for inoperable ...
Cancer News in Science Daily
New research has identified one of the key cancer-fighting mechanisms for sulforaphane, and suggests that this much-studied phytochemical found in broccoli and other foods may be able to move beyond cancer prevention and toward therapeutic use for advanced prostate cancer.
A mechanism that leads to resistance to targeted therapy in melanoma patients has been discovered by researchers who are investigating strategies to counteract it. Targeted biological therapy can reduce toxicity and improve outcomes for many cancer patients, when compared to the adverse effects of standard chemotherapeutic drugs. However, patients often develop resistance to these targeted therapies, resulting in more aggressive cells that can spread to other sites or cause regrowth of primary tumors.
New interactions between two molecules involved in acute myeloid leukemia (AML) have been found by scientists that may offer a new therapeutic target for cancer treatment. The scientists discovered that STAT3, a molecule which has the potential to cause cancer, associates with and regulates the levels of PRL-3, a gene which has been implicated in various types of cancers.
Even decades after being cured, many cancer survivors face physical and mental challenges resulting from their disease and its treatment. These findings could help clinicians and other experts develop interventions that are tailored to the specific types of problems and concerns that cancer survivors may experience.
Tambahkan Komentar